CDKN2A and melanoma: TERT and CDKN2A, PTEN, KIT, and TP53 mutations are frequently observed in melanoma tumors; moreover, the number of possible mutation types increases with CSD status, thus High-CSD melanomas have the highest tumor mutation burden.